Health service security of patients with 8 certain rare diseases: evidence from China’s national system for health service utilization of patients with healthcare insurance-Reference-Cited by-同舟云学术

Health service security of patients with 8 certain rare diseases: evidence from China’s national system for health service utilization of patients with healthcare insurance

Published:2019-08-20 Issue:1 Volume:14 Page:
ISSN:1750-1172
Container-title:Orphanet Journal of Rare Diseases
language:en
Short-container-title:Orphanet J Rare Dis

Author:

Min Rui,Zhang Xiaoyan,Fang Pengqian^ORCID,Wang Biyan,Wang He

Funder

National Natural Science Foundation of China

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Genetics(clinical),General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s13023-019-1165-7.pdf

Reference60 articles.

1. European Organisation for Rare Diseases (EURORDIS): Rare Diseases: Understanding This Public Health Priority. 2005. Available at https://www.eurordis.org/publication/rare-diseases-understanding-public-health-priority . Accessed 11 Dec 2017.

2. Yang L, Su C, Lee AM, Bai HX. Focusing on rare diseases in China: are we there yet? Orphanet J Rare Dis. 2015;10:142.

3. World Health Organization (WHO). Coming together to combat rare diseases. B World Health Organ. 2012;90(6):401–76.

4. European Organisation For Rare Diseases (EURORDIS): What is a rare disease? 2013. Available at https://www.eurordis.org/content/what-rare-disease . Accessed 11 Dec 2017.

5. Song P, He J, Li F, Jin C. Innovative measures to combat rare diseases in China: the national rare diseases registry system, larger-scale clinical cohort studies, and studies in combination with precision medicine research. Intractable Rare Dis Res. 2017;6(1):1–5.

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiple sclerosis: economic burden, therapeutic advances, and future forecasts in the Middle East and North Africa region;Expert Review of Pharmacoeconomics & Outcomes Research;2024-06-07

2. Measurement of Health-Related Quality of Life in Adult Patients with Rare disease: Based on the Chinese Value Set EQ-5D-5L;2024-05-23

3. Disease Burden and Costs Associated with Multiple Sclerosis in China: A Cross-sectional Analysis of Nationwide Survey Data;Neuroscience Bulletin;2023-11-02

4. Healthcare costs for patients with rare diseases: Evidence from China;The International Journal of Health Planning and Management;2023-10-10

5. Disease burden and costs associated with multiple sclerosis in China: A cross-sectional analysis of nationwide survey data;2023-07-05